A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma

Pier Luigi Zinzani, Monica Tani, Stefano Fanti, Vittorio Stefoni, Gerardo Musuraca, Umberto Vitolo, Alessio Perrotti, Mariapaola Fina, Enrico Derenzini, Michele Baccarani

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences